stem

A unique collection of 1880 stem cell differentiation signaling targeted compounds for high throughput and high content screening;

A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;

A unique collection of 530 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;

A unique collection of 924 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 280 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;

A collection of 19170 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of 4654 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3500 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A collection of 27752 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

A unique collection of 2240 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.

A unique collection of 4880 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1881 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.